Breaking the Mold: How R is Revolutionizing CSR Generation

There is no doubt that R, a statistical programming language, is gaining popularity in the life sciences sector. By removing costly SAS licensure barriers and tapping into a robust pool of talented R programmers, more biotechs can fund their drug development pipeline and deliver results sooner, benefiting us all.  Read how the FDA and industry innovators are uniting to make CSRs developed using R become the new normal.